{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T03:14:50Z","timestamp":1778210090620,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Key Medical Research Project of Jiangsu Provincial Health Commission","award":["K2023009"],"award-info":[{"award-number":["K2023009"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82474435"],"award-info":[{"award-number":["82474435"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82274428"],"award-info":[{"award-number":["82274428"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Natural Science Foundation","doi-asserted-by":"crossref","award":["BK20241996"],"award-info":[{"award-number":["BK20241996"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangsu Province Administration of Chinese Medicine","award":["ZT202102"],"award-info":[{"award-number":["ZT202102"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00210-026-05023-3","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T03:35:57Z","timestamp":1769139357000},"page":"9745-9760","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between three lipid-lowering drugs and amnesia: a real-world pharmacovigilance study"],"prefix":"10.1007","volume":"399","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0724-8115","authenticated-orcid":false,"given":"Jingyi","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianglong","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaogang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoyao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenlei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6701-8825","authenticated-orcid":false,"given":"Minghua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"issue":"12","key":"5023_CR1","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41569-018-0098-5","volume":"15","author":"BB Adhyaru","year":"2018","unstructured":"Adhyaru BB, Jacobson TA (2018) Safety and efficacy of statin therapy. Nat Rev Cardiol 15(12):757\u2013769. https:\/\/doi.org\/10.1038\/s41569-018-0098-5","journal-title":"Nat Rev Cardiol"},{"issue":"10","key":"5023_CR2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","volume":"14","author":"GJ Biessels","year":"2018","unstructured":"Biessels GJ, Despa F (2018) Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol 14(10):591\u2013604. https:\/\/doi.org\/10.1038\/s41574-018-0048-7","journal-title":"Nat Rev Endocrinol"},{"issue":"24","key":"5023_CR3","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","volume":"41","author":"J Bor\u00e9n","year":"2020","unstructured":"Bor\u00e9n J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, Daemen MJ, Demer LL, Hegele RA, Nicholls SJ, Nordestgaard B\u00f8rgeG, Watts GF, Bruckert E, Fazio S, Ference BA, Graham I, Horton JD, Landmesser U, Laufs U, Masana L, Pasterkamp G, Raal FJ, Ray KK, Schunkert H, Taskinen M-R, van de Sluis B, Wiklund O, Tokgozoglu L, Catapano AL, Ginsberg HN (2020) Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 41(24):2313\u20132330. https:\/\/doi.org\/10.1093\/eurheartj\/ehz962","journal-title":"Eur Heart J"},{"issue":"7","key":"5023_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrendo.2015.82","volume":"11","author":"RD Brinton","year":"2015","unstructured":"Brinton RD, Yao J, Yin F, Mack WJ, Cadenas E (2015) Perimenopause as a neurological transition state. Nat Rev Endocrinol 11(7):393\u2013405. https:\/\/doi.org\/10.1038\/nrendo.2015.82","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"5023_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40268-024-00474-6","volume":"24","author":"K Chen","year":"2024","unstructured":"Chen K, Chen Y, Huang H (2024) Exploring the relationship between atorvastatin and memory loss: a comprehensive analysis integrating real-world pharmacovigilance and Mendelian randomization. Drugs R D 24(2):317\u2013329. https:\/\/doi.org\/10.1007\/s40268-024-00474-6","journal-title":"Drugs R D"},{"issue":"8","key":"5023_CR6","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1001\/jama.2022.12138","volume":"328","author":"R Chou","year":"2022","unstructured":"Chou R, Cantor A, Dana T, Wagner J, Ahmed AY, Fu R, Ferencik M (2022) Statin use for the primary prevention of cardiovascular disease in adults: updated evidence report and systematic review for the US preventive services task force. JAMA 328(8):754\u2013771. https:\/\/doi.org\/10.1001\/jama.2022.12138","journal-title":"JAMA"},{"issue":"4","key":"5023_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14522","volume":"30","author":"Z Deng","year":"2024","unstructured":"Deng Z, Liu J, Gong H, Cai X, Xiao H, Gao W (2024) Psychiatric disorders associated with PCSK9 inhibitors: a real-world, pharmacovigilance study. CNS Neurosci Ther 30(4):e14522. https:\/\/doi.org\/10.1111\/cns.14522","journal-title":"CNS Neurosci Ther"},{"issue":"7","key":"5023_CR8","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1592\/phco.29.7.800","volume":"29","author":"MA Evans","year":"2009","unstructured":"Evans MA, Golomb BA (2009) Statin-associated adverse cognitive effects: survey results from 171 patients. Pharmacotherapy 29(7):800\u2013811. https:\/\/doi.org\/10.1592\/phco.29.7.800","journal-title":"Pharmacotherapy"},{"key":"5023_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.894685","volume":"13","author":"Z Feng","year":"2022","unstructured":"Feng Z, Li X, Tong WK, He Q, Zhu X, Xiang X, Tang Z (2022) Real-world safety of PCSK9 inhibitors: a pharmacovigilance study based on spontaneous reports in FAERS. Front Pharmacol 13:894685. https:\/\/doi.org\/10.3389\/fphar.2022.894685","journal-title":"Front Pharmacol"},{"key":"5023_CR10","doi-asserted-by":"publisher","first-page":"20240028","DOI":"10.59368\/agingbio.20240028","volume":"2","author":"A Ganne","year":"2024","unstructured":"Ganne A, Mainali N, Balasubramaniam M, Atluri R, Pahal S, Asante J, Nagel C, Vallurupalli S, Reis RJS, Ayyadevara S (2024) Ezetimibe lowers risk of Alzheimer\u2019s and related dementias over sevenfold, reducing aggregation in model systems by inhibiting 14-3-3G::hexokinase interaction. Aging Biol 2:20240028. https:\/\/doi.org\/10.59368\/agingbio.20240028","journal-title":"Aging Biol"},{"issue":"18","key":"5023_CR11","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1016\/j.jacc.2020.03.039","volume":"75","author":"B Gencer","year":"2020","unstructured":"Gencer B, Mach F, Guo J, Im KyungAh, Ruzza A, Wang H, Kurtz CE, Pedersen TR, Keech AC, Ott BR, Sabatine MS, Giugliano RP, FOURIER Investigators (2020) Cognition after lowering LDL-cholesterol with evolocumab. J Am Coll Cardiol 75(18):2283\u20132293. https:\/\/doi.org\/10.1016\/j.jacc.2020.03.039","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"5023_CR12","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1056\/NEJMoa1701131","volume":"377","author":"RP Giugliano","year":"2017","unstructured":"Giugliano RP, Mach F, Zavitz K, Kurtz C, Im K, Kanevsky E, Schneider J, Wang H, Keech A, Pedersen TR, Sabatine MS, Sever PS, Robinson JG, Honarpour N, Wasserman SM, Ott BR, EBBINGHAUS Investigators (2017) Cognitive function in a randomized trial of evolocumab. N Engl J Med 377(7):633\u2013643. https:\/\/doi.org\/10.1056\/NEJMoa1701131","journal-title":"N Engl J Med"},{"issue":"9","key":"5023_CR13","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","volume":"42","author":"PB Gorelick","year":"2011","unstructured":"Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S, American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia (2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 42(9):2672\u20132713. https:\/\/doi.org\/10.1161\/STR.0b013e3182299496","journal-title":"Stroke"},{"issue":"9","key":"5023_CR14","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1111\/bcp.15802","volume":"89","author":"CA Gravel","year":"2023","unstructured":"Gravel CA, Douros A (2023) Considerations on the use of different comparators in pharmacovigilance: a methodological review. Br J Clin Pharmacol 89(9):2671\u20132676. https:\/\/doi.org\/10.1111\/bcp.15802","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"5023_CR15","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.jacc.2021.07.022","volume":"78","author":"JP Howard","year":"2021","unstructured":"Howard JP, Wood FA, Finegold JA, Nowbar AN, Thompson DM, Arnold AD, Rajkumar CA, Connolly S, Cegla J, Stride C, Sever P, Norton C, Thom SAM, Shun-Shin MJ, Francis DP (2021) Side effect patterns in a crossover trial of statin, placebo, and no treatment. J Am Coll Cardiol 78(12):1210\u20131222. https:\/\/doi.org\/10.1016\/j.jacc.2021.07.022","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"5023_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010373","volume":"22","author":"WJ Hwang","year":"2020","unstructured":"Hwang WJ, Lee TY, Kim NS, Kwon JS (2020) The role of estrogen receptors and their signaling across psychiatric disorders. Int J Mol Sci 22(1):373. https:\/\/doi.org\/10.3390\/ijms22010373","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5023_CR17","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","volume":"80","author":"C Iadecola","year":"2013","unstructured":"Iadecola C (2013) The pathobiology of vascular dementia. Neuron 80(4):844\u2013866. https:\/\/doi.org\/10.1016\/j.neuron.2013.10.008","journal-title":"Neuron"},{"key":"5023_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.968039","volume":"14","author":"T Jamshidnejad-Tosaramandani","year":"2022","unstructured":"Jamshidnejad-Tosaramandani T, Kashanian S, Al-Sabri MH, Kro\u010dianov\u00e1 D, Clemensson LE, Gentreau M, Schi\u00f6th HB (2022) Statins and cognition: modifying factors and possible underlying mechanisms. Front Aging Neurosci 14:968039. https:\/\/doi.org\/10.3389\/fnagi.2022.968039","journal-title":"Front Aging Neurosci"},{"issue":"12","key":"5023_CR19","doi-asserted-by":"publisher","first-page":"5317","DOI":"10.1111\/bcp.15460","volume":"88","author":"C Ji","year":"2022","unstructured":"Ji C, Bai J, Zhou J, Zou Y, Yu M (2022) Adverse event profiles of PCSK9 inhibitors alirocumab and evolocumab: data mining of the FDA adverse event reporting system. Br J Clin Pharmacol 88(12):5317\u20135325. https:\/\/doi.org\/10.1111\/bcp.15460","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"5023_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-020-01125-1","volume":"19","author":"J-L Jin","year":"2020","unstructured":"Jin J-L, Zhang H-W, Cao Y-X, Liu H-H, Hua Qi, Li Y-F, Zhang Y, Guo Y-L, Wu N-Q, Zhu C-G, Xu R-X, Gao Y, Li X-L, Cui C-J, Liu G, Sun J, Dong Q, Santos R, Li J-J (2020) Long-term prognostic utility of low-density lipoprotein (LDL) triglyceride in real-world patients with coronary artery disease and diabetes or prediabetes. Cardiovasc Diabetol 19(1):152. https:\/\/doi.org\/10.1186\/s12933-020-01125-1","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"5023_CR21","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.amjcard.2008.01.041","volume":"101","author":"A Kashani","year":"2008","unstructured":"Kashani A, Sallam T, Bheemreddy S, Mann DL, Wang Y, Foody JM (2008) Review of side-effect profile of combination ezetimibe and statin therapy in randomized clinical trials. Am J Cardiol 101(11):1606\u20131613. https:\/\/doi.org\/10.1016\/j.amjcard.2008.01.041","journal-title":"Am J Cardiol"},{"key":"5023_CR22","doi-asserted-by":"publisher","DOI":"10.2174\/0118715303324204240905111835","author":"J Li","year":"2024","unstructured":"Li J, Gong J, Liu Z, Liu Y, He A, Wang Z (2024) Safety profile of statins for post-marketing adverse cardiovascular events: a real-world pharmacovigilance analysis. Endocr Metab Immune Disord Drug Targets. https:\/\/doi.org\/10.2174\/0118715303324204240905111835","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"5023_CR23","doi-asserted-by":"publisher","unstructured":"Libby P, Buring JE, Badimon L, Hansson G\u00f6ranK, Deanfield J, Bittencourt MS, Tokg\u00f6zo\u011flu L, Lewis EF (2019) Atherosclerosis. Nat Rev Dis Primers 5(1):56. https:\/\/doi.org\/10.1038\/s41572-019-0106-z","DOI":"10.1038\/s41572-019-0106-z"},{"issue":"8","key":"5023_CR24","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1161\/CIR.0000000000001303","volume":"151","author":"SS Martin","year":"2025","unstructured":"Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Bansal N, Beaton AZ, Commodore-Mensah Y, Currie ME, Elkind MSV, Fan W, Generoso G, Gibbs BB, Heard DG, Hiremath S, Johansen MC, Kazi DS, Ko D, Leppert MH, Magnani JW, Michos ED, Mussolino ME, Parikh NI, Perman SM, Rezk-Hanna M, Roth GA, Shah NS, Springer MV, St-Onge M-P, Thacker EL, Urbut SM, Van Spall HGC, Voeks JH, Whelton SP, Wong ND, Wong SS, Yaffe K, Palaniappan LP, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Committee (2025) 2025 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation 151(8):e41-660. https:\/\/doi.org\/10.1161\/CIR.0000000000001303","journal-title":"Circulation"},{"key":"5023_CR25","doi-asserted-by":"publisher","first-page":"CD003160","DOI":"10.1002\/14651858.CD003160.pub3","volume":"1","author":"B McGuinness","year":"2016","unstructured":"McGuinness B, Craig D, Bullock R, Passmore P (2016) Statins for the prevention of dementia. Cochrane Database Syst Rev 1:CD003160. https:\/\/doi.org\/10.1002\/14651858.CD003160.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"25","key":"5023_CR26","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","volume":"82","author":"GA Mensah","year":"2023","unstructured":"Mensah GA, Fuster V, Murray CJL, Roth GA, Global Burden of Cardiovascular Diseases and Risks Collaborators (2023) Global burden of cardiovascular diseases and risks, 1990-2022. J Am Coll Cardiol 82(25):2350\u20132473. https:\/\/doi.org\/10.1016\/j.jacc.2023.11.007","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"5023_CR27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s40256-023-00594-5","volume":"23","author":"DT Michaeli","year":"2023","unstructured":"Michaeli DT, Michaeli JC, Albers S, Boch T, Michaeli T (2023) Established and emerging lipid-lowering drugs for primary and secondary cardiovascular prevention. Am J Cardiovasc Drugs 23(5):477\u2013495. https:\/\/doi.org\/10.1007\/s40256-023-00594-5","journal-title":"Am J Cardiovasc Drugs"},{"key":"5023_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/292598","volume":"2012","author":"M Orth","year":"2012","unstructured":"Orth M, Bellosta S (2012) Cholesterol: its regulation and role in central nervous system disorders. Cholesterol 2012:292598. https:\/\/doi.org\/10.1155\/2012\/292598","journal-title":"Cholesterol"},{"issue":"3","key":"5023_CR29","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s11606-014-3115-3","volume":"30","author":"BR Ott","year":"2015","unstructured":"Ott BR, Daiello LA, Dahabreh IJ, Springate BA, Bixby K, Murali M, Trikalinos TA (2015) Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials. J Gen Intern Med 30(3):348\u2013358. https:\/\/doi.org\/10.1007\/s11606-014-3115-3","journal-title":"J Gen Intern Med"},{"key":"5023_CR30","doi-asserted-by":"publisher","unstructured":"Ouchi Y, Sasaki J, Arai H, Yokote K, Harada K, Katayama Y, Urabe T, Uchida Y, Hayashi M, Yokota N, Nishida H, Otonari T, Arai T, Sakuma I, Sakabe K, Yamamoto M, Kobayashi T, Oikawa S, Yamashita S, Rakugi H, Imai T, Tanaka S, Ohashi Y, Kuwabara M, Ito H (2019) Ezetimibe lipid-lowering trial on prevention of atherosclerotic cardiovascular disease in 75 or older (EWTOPIA 75). Circulation. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.039415","DOI":"10.1161\/CIRCULATIONAHA.118.039415"},{"issue":"5","key":"5023_CR31","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/HYPERTENSIONAHA.123.21356","volume":"81","author":"A Pacholko","year":"2024","unstructured":"Pacholko A, Iadecola C (2024) Hypertension, neurodegeneration, and cognitive decline. Hypertension 81(5):991\u20131007. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.123.21356","journal-title":"Hypertension"},{"issue":"7","key":"5023_CR32","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.jacc.2022.05.041","volume":"80","author":"DB Rosoff","year":"2022","unstructured":"Rosoff DB, Bell AS, Jung J, Wagner J, Mavromatis LA, Lohoff FW (2022) Mendelian randomization study of PCSK9 and HMG-CoA reductase inhibition and cognitive function. J Am Coll Cardiol 80(7):653\u2013662. https:\/\/doi.org\/10.1016\/j.jacc.2022.05.041","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"5023_CR33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1023\/a:1018975928974","volume":"11","author":"A Saheki","year":"1994","unstructured":"Saheki A, Terasaki T, Tamai I, Tsuji A (1994) In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitors. Pharm Res 11(2):305\u2013311. https:\/\/doi.org\/10.1023\/a:1018975928974","journal-title":"Pharm Res"},{"key":"5023_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-018-0110-3","volume":"7","author":"BG Schultz","year":"2018","unstructured":"Schultz BG, Patten DK, Berlau DJ (2018) The role of statins in both cognitive impairment and protection against dementia: a tale of two mechanisms. Transl Neurodegener 7:5. https:\/\/doi.org\/10.1186\/s40035-018-0110-3","journal-title":"Transl Neurodegener"},{"issue":"2","key":"5023_CR35","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3233\/JAD-2010-101179","volume":"23","author":"S Sierra","year":"2011","unstructured":"Sierra S, Ramos MC, Molina P, Esteo C, V\u00e1zquez JA, Burgos JS (2011) Statins as neuroprotectants: a comparative in vitro study of lipophilicity, blood-brain-barrier penetration, lowering of brain cholesterol, and decrease of neuron cell death. J Alzheimers Dis 23(2):307\u2013318. https:\/\/doi.org\/10.3233\/JAD-2010-101179","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"5023_CR36","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jacl.2010.08.026","volume":"4","author":"RJ Simpson","year":"2010","unstructured":"Simpson RJ, Mendys P (2010) The effects of adherence and persistence on clinical outcomes in patients treated with statins: a systematic review. J Clin Lipidol 4(6):462\u2013471. https:\/\/doi.org\/10.1016\/j.jacl.2010.08.026","journal-title":"J Clin Lipidol"},{"issue":"7","key":"5023_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076566","volume":"24","author":"M Sochocka","year":"2023","unstructured":"Sochocka M, Karska J, Pszczo\u0142owska M, Ochnik M, Fu\u0142ek M, Fu\u0142ek K, Kurpas D, Chojdak-\u0141ukasiewicz J, Rosner-Tenerowicz A, Leszek J (2023) Cognitive decline in early and premature menopause. Int J Mol Sci 24(7):6566. https:\/\/doi.org\/10.3390\/ijms24076566","journal-title":"Int J Mol Sci"},{"key":"5023_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2020.07.019","volume":"159","author":"J Soppert","year":"2020","unstructured":"Soppert J, Lehrke M, Marx N, Jankowski J, Noels H (2020) Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting. Adv Drug Deliv Rev 159:4\u201333. https:\/\/doi.org\/10.1016\/j.addr.2020.07.019","journal-title":"Adv Drug Deliv Rev"},{"issue":"25 Suppl 2","key":"5023_CR39","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","volume":"129","author":"NJ Stone","year":"2014","unstructured":"Stone NJ, Robinson JG, Lichtenstein AH, Merz CNB, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC, Watson K, Wilson PWF, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen W-K, Smith SC, Tomaselli GF, American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (2014) 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines. Circulation 129(25 Suppl 2):S1-45. https:\/\/doi.org\/10.1161\/01.cir.0000437738.63853.7a","journal-title":"Circulation"},{"issue":"8","key":"5023_CR40","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1001\/jamainternmed.2015.2092","volume":"175","author":"BL Strom","year":"2015","unstructured":"Strom BL, Schinnar R, Karlawish J, Hennessy S, Teal V, Bilker WB (2015) Statin therapy and risk of acute memory impairment. JAMA Intern Med 175(8):1399\u20131405. https:\/\/doi.org\/10.1001\/jamainternmed.2015.2092","journal-title":"JAMA Intern Med"},{"issue":"11","key":"5023_CR41","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.mayocp.2013.07.013","volume":"88","author":"KJ Swiger","year":"2013","unstructured":"Swiger KJ, Manalac RJ, Blumenthal RS, Blaha MJ, Martin SS (2013) Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects. Mayo Clin Proc 88(11):1213\u20131221. https:\/\/doi.org\/10.1016\/j.mayocp.2013.07.013","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"5023_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00415-009-5271-7","volume":"257","author":"S Trompet","year":"2010","unstructured":"Trompet S, van Vliet P, de Craen AJM, Jolles J, Buckley BM, Murphy MB, Ford I, Macfarlane PW, Sattar N, Packard CJ, Stott DJ, Shepherd J, Bollen ELEM, Blauw GJ, Jukema JW, Westendorp RGJ (2010) Pravastatin and cognitive function in the elderly. Results of the PROSPER Study. J Neurol 257(1):85\u201390. https:\/\/doi.org\/10.1007\/s00415-009-5271-7","journal-title":"J Neurol"},{"issue":"8","key":"5023_CR43","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/jama.2022.13044","volume":"328","author":"CM Mangione","year":"2022","unstructured":"US Preventive Services Task Force, Mangione CM, Barry MJ, Nicholson WK, Cabana M, Chelmow D, Coker TR, Davis EM, Donahue KE, Ja\u00e9n CR, Kubik M, Li Li, Ogedegbe G, Pbert L, Ruiz JM, Stevermer J, Wong JB (2022) Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force Recommendation Statement. JAMA 328(8):746\u2013753. https:\/\/doi.org\/10.1001\/jama.2022.13044","journal-title":"JAMA"},{"issue":"7","key":"5023_CR44","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1592\/phco.23.7.871.32720","volume":"23","author":"LR Wagstaff","year":"2003","unstructured":"Wagstaff LR, Mitton MW, Arvik BM, Doraiswamy PM (2003) Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy 23(7):871\u2013880. https:\/\/doi.org\/10.1592\/phco.23.7.871.32720","journal-title":"Pharmacotherapy"},{"issue":"1","key":"5023_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.70039","volume":"11","author":"FL Westphal Filho","year":"2025","unstructured":"Westphal Filho FL, Lopes PRM, de Almeida AM, Sano VKT, Tamashiro FM, Gon\u00e7alves OR, de Moraes FCA, Kreuz M, Kelly FA, Feitoza PVS (2025) Statin use and dementia risk: a systematic review and updated meta\u2010analysis. Alzheimer\u2019s Dement: Transl Res Clin Interv 11(1):e70039. https:\/\/doi.org\/10.1002\/trc2.70039","journal-title":"Alzheimer's Dement: Transl Res Clin Interv"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05023-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05023-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05023-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T02:43:51Z","timestamp":1778208231000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05023-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["5023"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05023-3","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"7 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study was a retrospective analysis based on the FDA Adverse Event Reporting System (FAERS), which is a publicly available, de-identified database. Ethical approval and Institutional Review Board (IRB) review were not required according to relevant institutional and national guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable. Patient data in the FAERS database are anonymized. Therefore, specific informed consent was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate declarations"}},{"value":"Clinical trial number: not applicable. This study is not a clinical trial and therefore was not registered in any clinical trial registry.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}